We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$505M
(+9%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$79.6M |
| 2 |
Tilray
TLRY
|
+$56.8M |
| 3 |
Aurora Cannabis
ACB
|
+$54.4M |
| 4 |
Canopy Growth
CGC
|
+$51.6M |
| 5 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$187M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$182M |
| 3 |
Hecla Mining
HL
|
+$43.6M |
| 4 |
Mativ Holdings
MATV
|
+$21.5M |
| 5 |
BlackBerry
BB
|
+$21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.87% |
| 2 | Healthcare | 15.14% |
| 3 | Materials | 14.7% |
| 4 | Financials | 7.38% |
| 5 | Consumer Staples | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Crane NXT
CXT
$3.12B
| $243K | ﹤0.01% |
+7,750
| New | +$253K |
2021 Q2
0 quarters
|
|
602
Aligos Therapeutics
ALGS
$33.7M
| $238K | ﹤0.01% |
450
-17
| -4% | -$10.8K |
2020 Q4
2 quarters
|
|
|
GMBL
603
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
| $235K | ﹤0.01% |
+1
| New | +$471K |
2021 Q2
0 quarters
|
|
|
EGLX
604
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
| $228K | ﹤0.01% |
+38,154
| New | +$260K |
2021 Q2
0 quarters
|
|
605
Logitech
LOGI
$15.1B
| $222K | ﹤0.01% |
1,801
-1,082
| -38% | -$127K |
2018 Q3
11 quarters
|
|
606
OraSure Technologies
OSUR
$263M
| $220K | ﹤0.01% |
21,224
-813
| -4% | -$7.91K |
2020 Q2
4 quarters
|
|
607
JOYY Inc
JOYY
$4.07B
| $219K | ﹤0.01% |
3,182
+928
| +41% | +$78.8K |
2018 Q3
11 quarters
|
|
608
GRAVITY
GRVY
$464M
| $212K | ﹤0.01% |
1,887
-11,801
| -86% | -$1.45M |
2018 Q3
11 quarters
|
|
609
DELISTED
Chimerix, Inc.
CMRX
| $192K | ﹤0.01% |
25,428
-862
| -3% | -$7.17K |
2020 Q2
4 quarters
|
|
610
DELISTED
WM TECHNOLOGY INC A
MAPS
| $176K | ﹤0.01% |
+9,814
| New | +$170K |
2021 Q2
0 quarters
|
|
611
Super Micro Computer
SMCI
$23.1B
| $169K | ﹤0.01% |
47,760
-4,870
| -9% | -$17.9K |
2020 Q3
3 quarters
|
|
612
Unisys
UIS
$164M
| $164K | ﹤0.01% |
6,412
-150
| -2% | -$3.79K |
2020 Q2
4 quarters
|
|
613
CEL-SCI Corp
CVM
$30.6M
| $155K | ﹤0.01% |
402
-12
| -3% | -$7.42K |
2020 Q2
4 quarters
|
|
614
Diamondrock Hospitality Co
DRH
$2.72B
| $150K | ﹤0.01% |
+15,570
| New | +$156K |
2021 Q2
0 quarters
|
|
615
XBiotech
XBIT
$65.9M
| $146K | ﹤0.01% |
8,846
-117
| -1% | -$1.98K |
2020 Q2
4 quarters
|
|
|
BRNS
616
DELISTED
Barinthus Biotherapeutics
BRNS
| $145K | ﹤0.01% |
+10,113
| New | +$150K |
2021 Q2
0 quarters
|
|
617
SIGA Technologies
SIGA
$229M
| $142K | ﹤0.01% |
22,432
-1,277
| -5% | -$8.77K |
2020 Q2
4 quarters
|
|
|
CDAK
618
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $123K | ﹤0.01% |
6,503
-100
| -2% | -$1.92K |
2020 Q4
2 quarters
|
|
|
SQZ
619
DELISTED
SQZ Biotechnologies Company
SQZ
| $114K | ﹤0.01% |
8,224
-308
| -4% | -$4.02K |
2020 Q4
2 quarters
|
|
620
Cue Biopharma
CUE
$136M
| $112K | ﹤0.01% |
309
| – | – |
2020 Q2
4 quarters
|
|
621
Tonix Pharmaceuticals
TNXP
$110M
| – | – |
0
| – | – |
2021 Q1
1 quarter
|
|
622
iBio
IBIO
$50.3M
| $96K | ﹤0.01% |
129
-3
| -2% | -$2.19K |
2020 Q2
4 quarters
|
|
|
PRTK
623
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $94K | ﹤0.01% |
13,844
-137
| -1% | -$1.11K |
2020 Q2
4 quarters
|
|
|
ATHX
624
DELISTED
Athersys, Inc. Common Stock
ATHX
| $92K | ﹤0.01% |
2,622
+200
| +8% | +$8.23K |
2020 Q2
4 quarters
|
|
625
Grid Dynamics Holdings
GDYN
$650M
| $91K | ﹤0.01% |
5,183
-111
| -2% | -$1.74K |
2020 Q4
2 quarters
|
|
Similar funds
PFM
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q2 2021 Portfolio in Review
As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.
- ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
- ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
- ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
- ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
- ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
- ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.
Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.